|
The Migraine Disease and Therapy Review provides prevalence numbers and percentages for major countries worldwide. Diagnosis of migraine is covered, along with information on treatment options for prophylactic, symptomatic, and triptan therapy. Dosing for common prophylactic therapies is provided, along with dosing and treatment costs of triptan therapies. Market size estimates and annual sales of leading therapies are provided.
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
|
|
I. OVERVIEW
II. INCIDENCE AND PREVALENCE
Prevalence Table: (US, Canada, France, Italy, Japan, China, Worldwide)
Prevalence Notes on Severity and Frequency
III. DIAGNOSIS
Example of Diagnosis Criteria Using International Headache Society ICHD-II
IV. TREATMENT
Prophylactic Therapy
Table: Products Used in the Prophylactic Treatment of Migraine
Symptomatic Therapy
Symptomatic Therapy - Triptans
Treatment of Cluster Headache
V. DOSING AND TREATMENT COSTS
VI. MARKET SIZE
VII. COMMENTS
VIII. REFERENCES/RESOURCES
|
|
